228 related articles for article (PubMed ID: 29241809)
1. Chemotherapy Use, End-of-Life Care, and Costs of Care Among Patients Diagnosed With Stage IV Pancreatic Cancer.
Bao Y; Maciejewski RC; Garrido MM; Shah MA; Maciejewski PK; Prigerson HG
J Pain Symptom Manage; 2018 Apr; 55(4):1113-1121.e3. PubMed ID: 29241809
[TBL] [Abstract][Full Text] [Related]
2. The end of life costs for Medicare patients with advanced ovarian cancer.
Urban RR; He H; Alfonso R; Hardesty MM; Goff BA
Gynecol Oncol; 2018 Feb; 148(2):336-341. PubMed ID: 29208368
[TBL] [Abstract][Full Text] [Related]
3. Resource Use in the Last Year of Life Among Patients Who Died With Versus of Prostate Cancer.
Dinan MA; Li Y; Zhang Y; Stewart SB; Curtis LH; George DJ; Reed SD
Clin Genitourin Cancer; 2016 Feb; 14(1):28-37.e2. PubMed ID: 26382223
[TBL] [Abstract][Full Text] [Related]
4. Trends in end-of-life care and health care spending in women with uterine cancer.
Margolis B; Chen L; Accordino MK; Clarke Hillyer G; Hou JY; Tergas AI; Burke WM; Neugut AI; Ananth CV; Hershman DL; Wright JD
Am J Obstet Gynecol; 2017 Oct; 217(4):434.e1-434.e10. PubMed ID: 28709581
[TBL] [Abstract][Full Text] [Related]
5. Neutropenia-related costs in patients treated with first-line chemotherapy for advanced non-small cell lung cancer.
Stokes ME; Muehlenbein CE; Marciniak MD; Faries DE; Motabar S; Gillespie TW; Lipscomb J; Knopf KB; Buesching DP
J Manag Care Pharm; 2009 Oct; 15(8):669-82. PubMed ID: 19803556
[TBL] [Abstract][Full Text] [Related]
6. Association between the Medicare hospice benefit and health care utilization and costs for patients with poor-prognosis cancer.
Obermeyer Z; Makar M; Abujaber S; Dominici F; Block S; Cutler DM
JAMA; 2014 Nov; 312(18):1888-96. PubMed ID: 25387186
[TBL] [Abstract][Full Text] [Related]
7. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
[TBL] [Abstract][Full Text] [Related]
8. Hospice Use, Hospitalization, and Medicare Spending at the End of Life.
Zuckerman RB; Stearns SC; Sheingold SH
J Gerontol B Psychol Sci Soc Sci; 2016 May; 71(3):569-80. PubMed ID: 26655645
[TBL] [Abstract][Full Text] [Related]
9. Associations Between End-of-Life Expenditures and Hospice Stay Length Vary by Clinical Condition and Expenditure Duration.
Hung P; Hsu SH; Wang SY
Value Health; 2020 Jun; 23(6):697-704. PubMed ID: 32540226
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic cancer treatment costs, including patient liability, by phase of care and treatment modality, 2000-2013.
Tramontano AC; Chen Y; Watson TR; Eckel A; Sheehan DF; Peters MLB; Pandharipande PV; Hur C; Kong CY
Medicine (Baltimore); 2019 Dec; 98(49):e18082. PubMed ID: 31804317
[TBL] [Abstract][Full Text] [Related]
11. Costs and trends in pancreatic cancer treatment.
O'Neill CB; Atoria CL; O'Reilly EM; LaFemina J; Henman MC; Elkin EB
Cancer; 2012 Oct; 118(20):5132-9. PubMed ID: 22415469
[TBL] [Abstract][Full Text] [Related]
12. End-of-life care for older cancer patients in the Veterans Health Administration versus the private sector.
Keating NL; Landrum MB; Lamont EB; Earle CC; Bozeman SR; McNeil BJ
Cancer; 2010 Aug; 116(15):3732-9. PubMed ID: 20564065
[TBL] [Abstract][Full Text] [Related]
13. The Cost of Hospice Services in Terminally Ill Patients With Head and Neck Cancer.
Enomoto LM; Schaefer EW; Goldenberg D; Mackley H; Koch WM; Hollenbeak CS
JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1066-74. PubMed ID: 26447873
[TBL] [Abstract][Full Text] [Related]
14. End-of-life care for lung cancer patients in the United States and Ontario.
Warren JL; Barbera L; Bremner KE; Yabroff KR; Hoch JS; Barrett MJ; Luo J; Krahn MD
J Natl Cancer Inst; 2011 Jun; 103(11):853-62. PubMed ID: 21593012
[TBL] [Abstract][Full Text] [Related]
15. Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database.
Davis KL; Mitra D; Kotapati S; Ibrahim R; Wolchok JD
Appl Health Econ Health Policy; 2009; 7(1):31-41. PubMed ID: 19558193
[TBL] [Abstract][Full Text] [Related]
16. Increased resource use in men with metastatic prostate cancer does not result in improved survival or quality of care at the end of life.
Golan R; Bernstein AN; Gu X; Dinerman BF; Sedrakyan A; Hu JC
Cancer; 2018 May; 124(10):2212-2219. PubMed ID: 29579318
[TBL] [Abstract][Full Text] [Related]
17. Aggressive Care near the End of Life for Cancer Patients in Medicare Accountable Care Organizations.
Kim H; Keating NL; Perloff JN; Hodgkin D; Liu X; Bishop CE
J Am Geriatr Soc; 2019 May; 67(5):961-968. PubMed ID: 30969439
[TBL] [Abstract][Full Text] [Related]
18. Survival and cost-effectiveness of hospice care for metastatic melanoma patients.
Huo J; Lairson DR; Du XL; Chan W; Buchholz TA; Guadagnolo BA
Am J Manag Care; 2014 May; 20(5):366-73. PubMed ID: 25181566
[TBL] [Abstract][Full Text] [Related]
19. Health System and Beneficiary Costs Associated With Intensive End-of-Life Medical Services.
Gidwani-Marszowski R; Asch SM; Mor V; Wagner TH; Faricy-Anderson K; Illarmo S; Hsin G; Patel MI; Ramchandran K; Lorenz KA; Needleman J
JAMA Netw Open; 2019 Sep; 2(9):e1912161. PubMed ID: 31560384
[TBL] [Abstract][Full Text] [Related]
20. Association Between Hospice Length of Stay, Health Care Utilization, and Medicare Costs at the End of Life Among Patients Who Received Maintenance Hemodialysis.
Wachterman MW; Hailpern SM; Keating NL; Kurella Tamura M; O'Hare AM
JAMA Intern Med; 2018 Jun; 178(6):792-799. PubMed ID: 29710217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
